|
NISCAIR ONLINE PERIODICALS REPOSITORY (NOPR) >
NISCAIR PUBLICATIONS >
Research Journals >
Journal of Intellectual Property Rights (JIPR) >
JIPR Vol.16 [2011] >
JIPR Vol.16(4) [July 2011] >
| Title: | The Emergence of New R&D Paradigms in the Indian Pharmaceutical Industry: Post TRIPS Period |
| Authors: | Mahajan, Madhur Mohit |
| Keywords: | TRIPS
Innovation
NCE
DMF |
| Issue Date: | Jul-2011 |
| Publisher: | NISCAIR-CSIR, India |
| Abstract: | India, being a signatory of WTO agreements, has moved from no or partial patent protection to full fledged patent protection. This represents a radical break from the past in which developing countries typically had only weak levels of patent protection. In this context, this research examines the steps involved in development of R&D capabilities in the Indian pharmaceutical firms as a response to strengthening of patent law. This paper analyses the post-TRIPS behaviour of domestic pharmaceutical firms in India with respect to R&D intensification, development of new molecules and enhanced DMF filings. The study establishes that firms in the post WTO era have increased their R&D efforts tremendously and are moving towards the development of advance level process and product R&D capabilities. Such firms have also opted for vigorous DMF filings abroad reflecting qualitative modifications and adjustments in its R&D capabilities in the production of exportables. |
| Page(s): | 321-329 |
| CC License: |  CC Attribution-Noncommercial-No Derivative Works 2.5 India |
| ISSN: | 0975-1076 (Online); 0971-7544 (Print) |
| Source: | JIPR Vol.16(4) [July 2011]
|
|
